Megna Michael R, CHIEF ACCOUNTING OFFICER exercised 2,362 shares of Kiniksa Pharmaceuticals International, plc ($KNSA) @ $0.00 ($0.00 total) on Sep 1, 2026

Megna Michael R – CHIEF ACCOUNTING OFFICER

Sep 1, 2026

52W Low$35.06

Current$80.4794.8% above low, 5.2% below high

52W High$82.94

2,362

Price

$0.00

Total Value

$0.00

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Megna Michael R
Title	CHIEF ACCOUNTING OFFICER
Transaction Date	Sep 1, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Disposed
Security	Restricted Share Unit (Class A Ordinary Share)
Derivative	Yes
Direct/Indirect	Direct
Filing Date	Sep 3, 2026
Shares Purchased	2,362
Price per Share	$0.00
Total Value	$0.00
Shares Owned After	4,725
Derivative	Derivative (Class A Ordinary Share)
Accession Number	0001464583-26-000008
Document	View SEC Filing